Congratulations to Trajan CSO on University of Tasmania award

Congratulations to Trajan CSO on University of Tasmania award

November 14, 2017

Hobart, Tasmania, Australia – 10 November 2017

Dr Andrew Gooley, Chief Scientific Officer (CSO) of Trajan Scientific and Medical (Trajan), proudly accepted the University of Tasmania Vice-Chancellor's award for outstanding contributions by adjunct and clinical title holders.

The award is in recognition of Andrew's sustained and outstanding contributions to ASTech, and more broadly to ACROSS over the past 5 years in the capacity of his adjunct position with the School of Physical Sciences, University of Tasmania.

Prof Brett Paull Director of ASTech and ACROSS, says “Andrew's enthusiasm and passion for science and innovation, and his engaged and inspiring interactions with all the ASTech students, is an asset to our center, which we simply couldn't do without."

Andrew received the award from Acting Vice-Chancellor Prof Mike Calford following an introduction from Prof Diane Nicol - Chair of Academic Senate at the annual Vice Chancellors Awards Ceremony held at the University's Sandy Bay campus, Hobart, Tasmania, on 10 November 2017.

The award is bestowed annually including an A$5,000 grant to support the recipient’s activities associated with the University. Trajan’s partnership with UTAS in ASTech aims to develop new capabilities and technologies that have the potential to progress the deployment of portable separation science systems into society, as well as training the next generation of industry-ready researchers.

“I’m honored to receive the award from the University, and on behalf of Trajan I’m delighted to acknowledge the commitment our organization has made in supporting industry-academia collaborations, none more evident than our joint program with the University of Tasmania through the foundation of ASTech and the training and mentoring of the next generation of young scientists and entrepreneurs.” said Andrew.

Dr Andrew Gooley, Trajan Chief Scientific Officer (right), receiving the award from Prof Mike Calford, Acting Vice-Chancellor, UTAS (left).
Photo: Dr Andrew Gooley, Trajan Chief Scientific Officer (right), receiving the award from Prof Mike Calford, Acting Vice-Chancellor, UTAS (left).

elebrating the moment with ASTech and ACROSS Director, Prof Brett Paull (right) and Andrew's partner Dr Wendy Gooley (left)
Photo: Celebrating the moment with ASTech and ACROSS Director, Prof Brett Paull (right) and Andrew's partner Dr Wendy Gooley (left).

Download
Press Release [PDF]

More information
UTAS media
ASTech
ACROSS

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1244 403 100
media@trajanscimed.com

 




Also in News

Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.
Trajan acquires HDExaminer Software from California-based, Sierra Analytics Inc.

February 15, 2023

Trajan Scientific and Medical announces the completion to acquire specialized software business, HDExaminer, from California-based, Sierra Analytics, Inc.

Read More

Trajan collaborates with Monash University for the development of HDX training centre
Trajan collaborates with Monash University for the development of HDX training centre

February 03, 2023

Trajan Scientific and Medical with Monash University would like to announce a collaboration for the development of an HDX training centre at Monash University's Proteomics and Metabolomics Facility (MPMF). This collaboration will provide the university with access to a Trajan HDX system and allow Trajan to provide HDX training to the proteomics community in the region.

Read More

Baker Institute research leads to simple tests for heart and diabetes disease
Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Collaboration has been key to a global health innovation to counter cardiovascular disease. One of Australia’s leading research facilities, the Baker Heart and Diabetes Institute, had the technology to potentially revolutionise testing for heart disease and diabetes, using just a single drop of blood. All it lacked for this global breakthrough was commercial nous, developmental infrastructure and marketing know-how. On the other hand, Trajan Scientific and Medical, a Melbourne-based ASX biotech company, had the technology and expertise to take products to market.

Read More